Skip to main content
DRMA
NASDAQ Life Sciences

Dermata Posts First $74K in Product Sales, But Cash Runs Dry by Q1 2027

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.72
Mkt Cap
$3.54M
52W Low
$0.603
52W High
$4.66
52W Position info
19% above low
Off High info
85% below high
Rel. Volume
Market data snapshot near publication time

DRMA sits 19% above its 52-week low of $0.603.

Summary

Dermata booked its first product revenue — $74K in Q3 2026 versus nothing a year ago — following the August 25 launch of its lead product. The top line is tiny, and the net loss widened to $2.8M from $1.7M as spending shifted toward commercialization. Cash and restricted cash fell to $5.0M at September 30 from $7.5M at year-end, and management says that funds operations only into Q1 2027, reaffirming going-concern doubt. The company also enrolled the first patient in the Tome Clearing Treatment acne trial, with launch targeted for H1 2027. With a micro-cap valuation and roughly a quarter of runway left, the next financing is the dominant risk; the August private placement raised $3.4M and the resale shares from it are now registered.

At the time of this announcement, DRMA was trading at $0.72 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.5M. The 52-week trading range was $0.60 to $4.66. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

DRMA - Latest Insights

DRMA
Nov 10, 2026, 4:07 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.702
Real-time Price: $0.6805 info
Change: -$0.0215 (-3%) info
Market Cap: $3.543M info
DRMA
Aug 17, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.43
Real-time Price: $0.6805 info
Change: -$0.7495 (-52%) info
Market Cap: $3.543M info
DRMA
Aug 11, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.71
Real-time Price: $0.6805 info
Change: -$1.03 (-60%) info
Market Cap: $3.543M info
DRMA
Aug 11, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.10
Real-time Price: $0.6805 info
Change: -$0.4195 (-38%) info
Market Cap: $3.543M info
DRMA
Aug 05, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.14
Real-time Price: $0.6805 info
Change: -$0.4595 (-40%) info
Market Cap: $3.543M info